29957469|t|Valproic acid attenuates Abeta25-35-induced neurotoxicity in PC12 cells through suppression of mitochondria-mediated apoptotic pathway.
29957469|a|Aggregation of amyloid-beta (Abeta) peptides is a pathological hallmark of Alzheimer's disease (AD). The purpose of the present study was to identify the protective role of valproic acid (VPA) against beta-amyloid protein fragment 25-35 (Abeta25-35)-caused neurotoxicity in PC12 cells. Different doses of VPA was added to cultures of differentiated PC12 cells, 1 h before Abeta25-35. We found that VPA effectively prevented Abeta25-35-stimulated cytotoxicity through attenuating apoptosis and increasing the ratio of Bcl-2/Bax in PC12 cells. VPA also significantly inhibited the generation of ROS induced by Abeta25-35 in PC12 cells in a dose-dependent manner. In addition, VPA significantly alleviated mitochondrial dysfunction through improvement of mitochondrial membrane potential, inhibition of cytochrome c release, and promotion of mitochondrial ATP synthesis. Furthermore, VPA treatment reduced the expression levels of proinflammatory cytokines and attenuated the activation of NF-kappaB signaling. In conclusion, our results suggested that VPA might serve as a novel protective agent against Abeta25-35-induced cytotoxicity in AD.
29957469	0	13	Valproic acid	Chemical	MESH:D014635
29957469	25	35	Abeta25-35	Chemical	-
29957469	44	57	neurotoxicity	Disease	MESH:D020258
29957469	61	65	PC12	CellLine	CVCL:0481
29957469	165	170	Abeta	Gene	54226
29957469	211	230	Alzheimer's disease	Disease	MESH:D000544
29957469	232	234	AD	Disease	MESH:D000544
29957469	309	322	valproic acid	Chemical	MESH:D014635
29957469	324	327	VPA	Chemical	MESH:D014635
29957469	374	384	Abeta25-35	Chemical	-
29957469	393	406	neurotoxicity	Disease	MESH:D020258
29957469	410	414	PC12	CellLine	CVCL:0481
29957469	441	444	VPA	Chemical	MESH:D014635
29957469	485	489	PC12	CellLine	CVCL:0481
29957469	508	518	Abeta25-35	Chemical	-
29957469	534	537	VPA	Chemical	MESH:D014635
29957469	560	570	Abeta25-35	Chemical	-
29957469	582	594	cytotoxicity	Disease	MESH:D064420
29957469	653	658	Bcl-2	Gene	24224
29957469	659	662	Bax	Gene	24887
29957469	666	670	PC12	CellLine	CVCL:0481
29957469	678	681	VPA	Chemical	MESH:D014635
29957469	729	732	ROS	Chemical	-
29957469	744	754	Abeta25-35	Chemical	-
29957469	758	762	PC12	CellLine	CVCL:0481
29957469	810	813	VPA	Chemical	MESH:D014635
29957469	839	864	mitochondrial dysfunction	Disease	MESH:D028361
29957469	989	992	ATP	Chemical	MESH:D000255
29957469	1017	1020	VPA	Chemical	MESH:D014635
29957469	1186	1189	VPA	Chemical	MESH:D014635
29957469	1238	1248	Abeta25-35	Chemical	-
29957469	1257	1269	cytotoxicity	Disease	MESH:D064420
29957469	1273	1275	AD	Disease	MESH:D000544
29957469	Negative_Correlation	MESH:D014635	MESH:D064420
29957469	Association	MESH:D000544	54226
29957469	Positive_Correlation	MESH:D000255	MESH:D014635
29957469	Negative_Correlation	MESH:D014635	MESH:D000544
29957469	Positive_Correlation	MESH:D014635	24887
29957469	Positive_Correlation	MESH:D014635	24224
29957469	Negative_Correlation	MESH:D014635	MESH:D028361
29957469	Negative_Correlation	MESH:D014635	MESH:D020258

